PMCB
PharmaCyte Biotech·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
PMCB Filings
Filing Date
Form Description
Form Type
2025-11-18
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-18 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-18
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-11-18 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-11-18
Form 8-K/A - Current report: [Amend]
Key Events
2025-11-18 · Key Events
Form 8-K/A - Current report: [Amend]
2025-11-07
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-07 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-10-31
Form 8-K - Current report
Key Events
2025-10-31 · Key Events
Form 8-K - Current report
2025-10-06
Form DEF 14A - Other definitive proxy statements
Key Events
2025-10-06 · Key Events
Form DEF 14A - Other definitive proxy statements
2025-09-29
Form EFFECT - Notice of Effectiveness
2025-09-29 ·
Form EFFECT - Notice of Effectiveness
2025-09-24
Form PRE 14A - Other preliminary proxy statements
Key Events
2025-09-24 · Key Events
Form PRE 14A - Other preliminary proxy statements
2025-09-17
Form S-3 - Registration statement under Securities Act of 1933
2025-09-17 ·
Form S-3 - Registration statement under Securities Act of 1933
2025-09-15
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-09-15 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
